Recently, in acute myeloid leukemia, BEND3 is identified as a key gene whose deletion results in resistance to TAK-243, a first-in-class inhibitor of ubiquitin-like modifier activating enzyme 1, via regulating breast cancer resistance protein (BCRP)63. The gene discussed is ABCG2; the disease is acute myeloid leukemia.